Search Results 341-350 of 16284 for actinic keratosis clinical trials
Phase 0 trials are small trials ... 1), stage III (lymph node or in transit lesions) ... Contact information: Cancer Center Clinical Trials Referral Office.
Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This clinical trial is studying the side effects and best dose of ...
Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
The primary purpose of this study is to compare the diagnostic utility of 7T MRI versus 3T MRI in the detection of subtle epileptogenic lesions in the brain. A ...
The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...
About this study. This study will be a Phase I/II, open-label, non-randomized, dose-finding trial conducted at multiple clinical centers.
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
Clinical Trials · Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy · More about research at Mayo Clinic · Mayo Clinic Footer · Mayo Clinic Privacy ...
The primary objective of this study is to evaluate overall response rate (ORR) following treatment with idelalisib plus rituximab in participants with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.